Kara Lindsay
Family Medicine · Gilbert, AZNPI 1730789876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,684 and has fallen 89.5% since, to $177 in 2025.
Across 186 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$793
- AstraZeneca$540
- Novo Nordisk$373
- Amgen$200
- Lilly USA, LLC$187
- Pfizer$180
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$441%
- Food & beverage$3,89798%
- Entertainment$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $793 |
| AstraZeneca | 20 | $540 |
| Novo Nordisk | 11 | $373 |
| Amgen | 11 | $200 |
| Lilly USA, LLC | 15 | $187 |
| Pfizer | 10 | $180 |
| Novartis | 8 | $169 |
| Bayer | 4 | $163 |
| Boehringer Ingelheim | 6 | $112 |
| Paratek Pharmaceuticals, Inc. | 1 | $109 |
| Corcept Therapeutics | 6 | $100 |
| Dexcom, Inc. | 4 | $90 |
| Mylan Specialty L.p. | 5 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $67 |
| Intuitive Surgical | 1 | $62 |
| Merck | 4 | $61 |
| GSK | 3 | $59 |
| Merz North America, Inc. | 2 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $56 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Gilead | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Boston Scientific | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Johnson & Johnson | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $21 |
| Optos, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,962 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 17 | $121 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gilbert
- Sunildat MaheshwariGilbert$24K
- David BentonGilbert$18K
- Zachary OrtizGilbert$13K
- Steven ReederGilbert$13K
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.